Milestone Pharmaceuticals Inc. (MIST) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Milestone Pharmaceuticals Inc. (MIST) short-term stock forecast for year 2025, month by month, and long-term MIST price prediction for years 2025 to 2050. Check MIST historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest MIST news and headlines.
1 Month Prediction
$2.90 [126.64%]
3 Month Prediction
$2.54 [98.17%]
6 Month Prediction
$2.17 [69.56%]
1 Year Prediction
$1.26 [-1.81%]
3 Year Prediction
$1.00 [-21.87%]
5 Year Prediction
$1.00 [-21.87%]
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops treatments for episodic cardiovascular conditions. Its lead investigational product is etripamil, a fast-acting calcium channel blocker administered as a nasal spray.
It is designed for self-administration by patients to rapidly terminate episodes of paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR).
The company was founded in 2003, the company is headquartered in Montreal, Canada, with a U.S. subsidiary in Charlotte, North Carolina.
Milestone Pharmaceuticals Inc. (MIST) Historical Performance
IPO Date
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) went public on 10 May, 2019.
Change
Since inception, MIST has decreased by 93.82%. In the last 5 years, MIST has fallen from $3.16 to $1.28, a massive -59.49% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $9.19 and a low of $0.80.
52 Week Range
$0.625
$2.75
The current price $1.28 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
MIST Stock Price History
Based on MIST stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the MIST stock has fallen from $1.84 - $22.05 to $0.8 - $1.97, which is down -92.78%. Currently, the stock follows downward trend.
Here, we have calculated stock range of MIST, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $1.84 - $22.05 | $7.98 | -59.42 | 1 Year Change |
| 2021 | $5.47 - $7.38 | $6.08 | -69.08 | 2 Year Change |
| 2022 | $3.96 - $9.19 | $6.33 | -67.81 | 3 Year Change |
| 2023 | $1.67 - $3.94 | $3.15 | -83.98 | 4 Year Change |
| 2024 | $1.32 - $2.36 | $1.64 | -91.66 | 5 Year Change |
| 2025 | $0.8 - $1.97 | $1.42 | -92.78 | 6 Year Change |
MIST Price Performance
6-Month Performance
MIST stock dropped by 35.68% in the last six months.
1-Year Performance
The stock has trended downwards by 14.67% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 77.18%.
5-Year Performance
In the last 5 years, the stock has gone down by 59.49%.
According to Milestone Pharmaceuticals Inc.'s historical data, below graph gives us the exact picture of how the MIST stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
58.15% ↓
2021
2.24% ↓
2022
39.54% ↓
2023
57.83% ↓
2024
41.32% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Milestone Pharmaceuticals Inc. (MIST) Financials & Stock Analysis
Market Capitalization
Milestone Pharmaceuticals Inc. has a market capitalization of $68.29M, which places MIST in the micro-cap category.
Fundamental Analysis
EPS: $nan (Q4), $nan (1Y)
EPS decreased nan% since last quarter, and decreased nan% since last year.
Net Income: $-12.36 M (Q4), $-41.52 M (1Y)
Net Income increased 30.98% since last quarter, and decreased 30.44% since last year.
Free Cash Flow: $-6.87 M (Q4), $-28.88 M (1Y)
Free Cash Flow decreased N/A since last quarter, and decreased 37.94% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for MIST stock. These indicators help you understand Milestone Pharmaceuticals Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for MIST stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.87 |
| SMA50 | $1.54 |
| SMA200 | $1.65 |
| RSI | 91.48 |
| Beta | 1.38 |
SMA20 < Current Price
This signals MIST stock is in short-term bullish momentum.
SMA50 > Current Price
This signals MIST stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals MIST stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for MIST stock is Bearish. Out of all indicators, 2 indicates bullish signals, 7 signals bearish trends and 0 gives neutral trends. The MIST stock forecast was last updated on 26 April, 2025.
Milestone Pharmaceuticals Inc. (MIST) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.41 by the end of 2025, and can reach around $1.57 to $1.01 in 2026. And, the long-term forecast suggests that the stock may further drop to $1.41 - $1.19 in 2028, and $0.73 - $1.08 by 2031. So, the MIST stock shows a strong upward trend in the next several years.
Short-term MIST Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-05 | $2.90 | 126.56% |
| 2025-06 | $2.61 | 103.91% |
| 2025-07 | $2.54 | 98.44% |
| 2025-08 | $2.35 | 83.59% |
| 2025-09 | $2.34 | 82.81% |
| 2025-10 | $2.17 | 69.53% |
| 2025-11 | $3.07 | 139.84% |
| 2025-12 | $1.41 | 10.16% |
In 2025, the MIST stock price is expected to fluctuate between $1.41 and $3.07. According to the monthly forecast, the stock could rise to $1.41 by December 2024. If compared to the MIST's current price, the stock could gain 10.16% by the end of this year.
Long-term MIST Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $1.57 | $1.76 | $1.01 | -21.09% |
| 2027 | $0.99 | $0.96 | $0.99 | -22.66% |
| 2028 | $1.41 | $1.07 | $1.19 | -7.03% |
| 2029 | $1.39 | $1.17 | $0.92 | -28.12% |
| 2030 | $1.08 | $0.79 | $0.77 | -39.84% |
| 2031 | $0.73 | $1.11 | $1.08 | -15.62% |
| 2032 | $1.49 | $0.92 | $1.12 | -12.5% |
| 2033 | $1.10 | $0.99 | $0.98 | -23.44% |
| 2034 | $1.10 | $1.12 | $1.07 | -16.41% |
| 2035 | $1.02 | $1.02 | $1.15 | -10.16% |
| 2036 | $1.48 | $1.12 | $1.11 | -13.28% |
| 2037 | $1.11 | $0.81 | $1.34 | 4.69% |
| 2038 | $0.75 | $0.89 | $1.07 | -16.41% |
| 2039 | $0.99 | $1.03 | $0.99 | -22.66% |
| 2040 | $0.89 | $1.04 | $1.17 | -8.59% |
| 2041 | $1.03 | $0.74 | $0.97 | -24.22% |
| 2042 | $0.80 | $1.20 | $0.78 | -39.06% |
| 2043 | $0.93 | $0.64 | $1.48 | 15.63% |
| 2044 | $1.61 | $1.37 | $1.12 | -12.5% |
| 2045 | $0.89 | $1.15 | $0.95 | -25.78% |
| 2046 | $1.06 | $1.01 | $0.40 | -68.75% |
| 2047 | $1.22 | $1.47 | $1.34 | 4.69% |
| 2048 | $0.66 | $1.29 | $0.85 | -33.59% |
| 2049 | $0.78 | $1.07 | $0.63 | -50.78% |
| 2050 | $0.90 | $0.70 | $1.61 | 25.78% |
| 2051 | $0.86 | $0.86 | $1.30 | 1.56% |
Milestone Pharmaceuticals Inc. (MIST) Stock Price Prediction & Forecast 2025
At the start of 2025, the MIST stock was at $1.97. Today, it is trading at $1.28, which is -35.03% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.41 by December 2025 with a 10.16% change.
Milestone Pharmaceuticals Inc. (MIST) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the MIST stock. During this period, the MIST's price is forecasted to shift from $1.57 to $0.77, which is -50.96% loss.
In 2026, the stock would possibly open at $1.57, escalates to $1.76 by mid-year, and wraps up at $1.01, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $1.08, soar to $0.79 by mid-year, and finish at $0.77, which is -39.47% change from current price.
Milestone Pharmaceuticals Inc. (MIST) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.73 to $1.17, which is up -15.63%
In 2031, we can expect MIST to fluctuate between $0.73 and $1.08, a shift indicating a -15.63% loss by year-end compared to current price. And Until 2040, MIST can likely vary from $0.89 to $1.17. By the end of 2040, the stock could record a -8.39% fall from today's stock price.
Milestone Pharmaceuticals Inc. (MIST) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the MIST stock can see an an upturn from $1.03 to $1.61 in this period. In 2041, the stock can experience a low of $0.74 by mid-year, closing the year at $0.97. This results in a -42.08% decrease from today.
Moving towards the end of 2050, MIST is projected to open the year at $0.90. The stock may dip to $0.70 during mid-year and finish the year at $1.61. Compared to the stock's current price, this translates to an overall gain of 25.76% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
MIST Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | - | $1.99 | 71.55% ▲ | -49.75 ▼ |
| CORT | Corcept Therapeutics Incorporated | - | $114.22 | 0.00% ▼ | $0.09 ▲ |
| GLTO | Galecto, Inc. | - | $6.65 | 51.83% ▲ | $32.48 ▲ |
| RNAZ | TransCode Therapeutics, Inc. | - | $1.38 | -30.31% ▼ | -27.53 ▼ |
| CRVO | CervoMed Inc. | - | $6.91 | 208.48% ▲ | $257.27 ▲ |
Last updated Apr 26 at 7:46 AM
MIST : Buy, Sell Or Hold?
Analyst Ratings
Based on 2 analysts, 1 rated as a strong buy, 0 recommended a buy, 1 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 3 analysts, 1 analysts gave a strong buy rating, 1 a buy rating, 1 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for MIST stock is Buy.
Expert Analysis
According to MIST short-term and long-term forecast, Milestone Pharmaceuticals Inc. shares are projected to go up by 25.78%, and reach a value of $1.61 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 57.142857142857146, which signals Greed. Also, MIST has recorded 15/30 green days, which reflects a 68.18181818181817% positivity rate with a price volatility of 0.14%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that MIST stock is undervalued. So, Based on MIST prediction and analysis, it may be the best time to hold MIST stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "MIST” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.